Abdul-Ghani, Muhammad, Ralph A. DeFronzo, Stefano Del Prato, Robert Chilton, Rajvir Singh, and Robert E.J. Ryder, ‘Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?’, Diabetes Care, 40.7 (2017), 813–20 <https://doi.org/10.2337/dc16-2736>
Adamsson Eryd, S., A.-M. Svensson, S. Franzén, B. Eliasson, P. M. Nilsson, and S. Gudbjörnsdottir, ‘Risk of Future Microvascular and Macrovascular Disease in People with Type 1 Diabetes of Very Long Duration: A National Study with 10-Year Follow-Up’, Diabetic Medicine, 34.3 (2017), 411–18 <https://doi.org/10.1111/dme.13266>
Andersson, Daniel P, Ylva Trolle Lagerros, Alessandra Grotta, Rino Bellocco, Mikael Lehtihet, and Martin J Holzmann, ‘Association between Treatment for Erectile Dysfunction and Death or Cardiovascular Outcomes after Myocardial Infarction’, Heart, 2017 <https://doi.org/10.1136/heartjnl-2016-310746>
‘Assessing the Relationship between Admission Glucose Levels, Subsequent Length of Hospital Stay, Readmission and Mortality.’, Prime <https://wwww.unboundmedicine.com/medline/citation/22586788/Assessing_the_relationship_between_admission_glucose_levels_subsequent_length_of_hospital_stay_readmission_and_mortality_>
Atkinson, Mark A, George S Eisenbarth, and Aaron W Michels, ‘Type 1 Diabetes’, The Lancet, 383.9911 (2014), 69–82 <https://doi.org/10.1016/S0140-6736(13)60591-7>
Azmi, Shazli, Maryam Ferdousi, Uazman Alam, Ioannis N. Petropoulos, Georgios Ponirakis, Andrew Marshall, and others, ‘Small-Fibre Neuropathy in Men with Type 1 Diabetes and Erectile Dysfunction: A Cross-Sectional Study’, Diabetologia, 2017 <https://doi.org/10.1007/s00125-017-4245-z>
Bangalore, S., S. Kumar, I. Lobach, and F. H. Messerli, ‘Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials’, Circulation, 123.24 (2011), 2799–2810 <https://doi.org/10.1161/CIRCULATIONAHA.110.016337>
Barzilay, J. I., B. R. Davis, S. L. Pressel, J. A. Cutler, P. T. Einhorn, H. R. Black, and others, ‘Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study’, Circulation: Cardiovascular Quality and Outcomes, 5.2 (2012), 153–62 <https://doi.org/10.1161/CIRCOUTCOMES.111.962522>
Bianchi, Cristina, Roberto Miccoli, and Stefano Del Prato, ‘Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?’, Current Diabetes Reports, 13.3 (2013), 403–10 <https://doi.org/10.1007/s11892-013-0371-2>
———, ‘Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?’, Current Diabetes Reports, 13.3 (2013), 403–10 <https://doi.org/10.1007/s11892-013-0371-2>
Black, J. A., S. J. Sharp, N. J. Wareham, A. Sandbaek, G. E. Rutten, T. Lauritzen, and others, ‘Change in Cardiovascular Risk Factors Following Early Diagnosis of Type 2 Diabetes: A Cohort Analysis of a Cluster-Randomised Trial’, British Journal of General Practice, 64.621 (2014), e208–16 <https://doi.org/10.3399/bjgp14X677833>
Boulton, Andrew JM, William J Jeffcoate, Teresa LZ Jones, and Jan S Ulbrecht, ‘International Collaborative Research on Charcot’s Disease - 2009’, The Lancet, 373.9658 (2009), 105–6 <https://doi.org/10.1016/S0140-6736(09)60019-2>
Boussageon, R., T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, B. Kassai, and others, ‘Effect of Intensive Glucose Lowering Treatment on All Cause Mortality, Cardiovascular Death, and Microvascular Events in Type 2 Diabetes: Meta-Analysis of Randomised Controlled Trials’, BMJ, 343.jul26 1 (2011), d4169–d4169 <https://doi.org/10.1136/bmj.d4169>
Braffett, Barbara H., Hunter Wessells, and Aruna V. Sarma, ‘Urogenital Autonomic Dysfunction in Diabetes’, Current Diabetes Reports, 16.12 (2016) <https://doi.org/10.1007/s11892-016-0824-5>
Çakici, N., T. M. Fakkel, J. W. van Neck, A. P. Verhagen, and J. H. Coert, ‘Systematic Review of Treatments for Diabetic Peripheral Neuropathy’, Diabetic Medicine, 33.11 (2016), 1466–76 <https://doi.org/10.1111/dme.13083>
———, ‘Systematic Review of Treatments for Diabetic Peripheral Neuropathy’, Diabetic Medicine, 33.11 (2016), 1466–76 <https://doi.org/10.1111/dme.13083>
‘Cardiovascular Outcome Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0140673614607947>
Cefalu, William T., Julio Rosenstock, Derek LeRoith, Lawrence Blonde, and Matthew C. Riddle, ‘Getting to the "Heart” of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory”’, Diabetes Care, 39.5 (2016), 664–67 <https://doi.org/10.2337/dc16-0405>
Chatterjee, Sudesna, Kamlesh Khunti, and Melanie J Davies, ‘Type 2 Diabetes’, The Lancet, 2017 <https://doi.org/10.1016/S0140-6736(17)30058-2>
Cheung, Ning, Paul Mitchell, and Tien Yin Wong, ‘Diabetic Retinopathy’, The Lancet, 376.9735 (2010), 124–36 <https://doi.org/10.1016/S0140-6736(09)62124-3>
Chloe L. Edridge, ‘Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies’, PLoS ONE, 10.6 (2015) <https://doi.org/doi: 10.1371/journal.pone.0126427>
Clokie, M., A. L. Greenway, K. Harding, N. J. Jones, K. Vedhara, F. Game, and others, ‘New Horizons in the Understanding of the Causes and Management of Diabetic Foot Disease: Report from the 2017 Diabetes UK Annual Professional Conference Symposium’, Diabetic Medicine, 34.3 (2017), 305–15 <https://doi.org/10.1111/dme.13313>
Dahlöf, Björn, Peter S Sever, Neil R Poulter, Hans Wedel, D Gareth Beevers, Mark Caulfield, and others, ‘Prevention of Cardiovascular Events with an Antihypertensive Regimen of Amlodipine Adding Perindopril as Required versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Trial’, The Lancet, 366.9489 (2005), 895–906 <https://doi.org/10.1016/S0140-6736(05)67185-1>
Dana Dabelea, ‘Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood’, JAMA, 317.8, 825–35 <https://doi.org/10.1001/jama.2017.0686>
Denig, P., J. Schuling, F. Haaijer-Ruskamp, and J. Voorham, ‘Effects of a Patient Oriented Decision Aid for Prioritising Treatment Goals in Diabetes: Pragmatic Randomised Controlled Trial’, BMJ, 349.sep25 6 (2014), g5651–g5651 <https://doi.org/10.1136/bmj.g5651>
Dhatariya, K., N. Levy, A. Kilvert, B. Watson, D. Cousins, D. Flanagan, and others, ‘NHS Diabetes Guideline for the Perioperative Management of the Adult Patient with Diabetes’, Diabetic Medicine, 29.4 (2012), 420–33 <https://doi.org/10.1111/j.1464-5491.2012.03582.x>
Dhatariya, Ketan K., and Priyathama Vellanki, ‘Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)’, Current Diabetes Reports, 17.5 (2017) <https://doi.org/10.1007/s11892-017-0857-4>
‘Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: A Collaborative Meta-Analysis of 102 Prospective Studies’, The Lancet, 375.9733 (2010), 2215–22 <https://doi.org/10.1016/S0140-6736(10)60484-9>
‘Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death’, New England Journal of Medicine, 364.9 (2011), 829–41 <https://doi.org/10.1056/NEJMoa1008862>
‘Diabetes Mellitus Type 2: A Driving Force for Urological Complications - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1043276016000321>
‘———’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1043276016000321>
‘Diabetic Foot Problems: Prevention and Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng19>
Duckworth, William, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D. Reaven, and others, ‘Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes’, New England Journal of Medicine, 360.2 (2009), 129–39 <https://doi.org/10.1056/NEJMoa0808431>
Dwamena, Francesca, Margaret Holmes-Rovner, Carolyn M Gaulden, Sarah Jorgenson, Gelareh Sadigh, Alla Sikorskii, and others, ‘Interventions for Providers to Promote a Patient-Centred Approach in Clinical Consultations’, in Cochrane Database of Systematic Reviews (Chichester, UK: John Wiley & Sons, Ltd, 1996) <https://doi.org/10.1002/14651858.CD003267.pub2>
‘Effect of Intensive Blood-Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34)’, The Lancet, 352.9131 (1998), 854–65 <https://doi.org/10.1016/S0140-6736(98)07037-8>
‘Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus’, New England Journal of Medicine, 362.17 (2010), 1563–74 <https://doi.org/10.1056/NEJMoa1001282>
‘Effects of Different Blood Pressure–Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus’, Archives of Internal Medicine, 165.12 (2005) <https://doi.org/10.1001/archinte.165.12.1410>
‘Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus’, New England Journal of Medicine, 362.17 (2010), 1575–85 <https://doi.org/10.1056/NEJMoa1001286>
‘———’, New England Journal of Medicine, 362.17 (2010), 1575–85 <https://doi.org/10.1056/NEJMoa1001286>
‘Effects of Intensive Glucose Lowering in Type 2 Diabetes’, New England Journal of Medicine, 358.24 (2008), 2545–59 <https://doi.org/10.1056/NEJMoa0802743>
‘Effects of Reducing Blood Pressure on Renal Outcomes in Patients with Type 2 Diabetes: Focus on SGLT2 Inhibitors and EMPA-REG OUTCOME - ClinicalKey’ <https://www.clinicalkey.com/#!/content/journal/1-s2.0-S1262363617300022>
Ele Ferrannini, ‘Impact of Glucose-Lowering Drugs on Cardiovascular Disease in Type 2 Diabetes’, European Heart Journal, 36.34 (2015), 2288–96 <http://eurheartj.oxfordjournals.org/content/36/34/2288>
Elliott, William J, and Peter M Meyer, ‘Incident Diabetes in Clinical Trials of Antihypertensive Drugs: A Network Meta-Analysis’, The Lancet, 369.9557 (2007), 201–7 <https://doi.org/10.1016/S0140-6736(07)60108-1>
Ferrannini, Ele, and William C Cushman, ‘Diabetes and Hypertension: The Bad Companions’, The Lancet, 380.9841 (2012), 601–10 <https://doi.org/10.1016/S0140-6736(12)60987-8>
Filippatos, Theodosios, Vasilios Tsimihodimos, Eleni Pappa, and Moses Elisaf, ‘Pathophysiology of Diabetic Dyslipidaemia’, Current Vascular Pharmacology, 15.999 (2017), 1–1
Fisher, L., J. S. Gonzalez, and W. H. Polonsky, ‘The Confusing Tale of Depression and Distress in Patients with Diabetes: A Call for Greater Clarity and Precision’, Diabetic Medicine, 31.7 (2014), 764–72 <https://doi.org/10.1111/dme.12428>
Foresta, C., A. Ferlin, A. Lenzi, and P. Montorsi, ‘The Great Opportunity of the Andrological Patient: Cardiovascular and Metabolic Risk Assessment and Prevention’, Andrology, 2017 <https://doi.org/10.1111/andr.12342>
Fox, Caroline S., Sherita Hill Golden, Cheryl Anderson, George A. Bray, Lora E. Burke, Ian H. de Boer, and others, ‘Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association’, Diabetes Care, 38.9 (2015), 1777–1803 <https://doi.org/10.2337/dci15-0012>
‘Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes’, New England Journal of Medicine, 376.16 (2017), 1507–16 <https://doi.org/10.1056/NEJMoa1612836>
Gæde, Peter, Henrik Lund-Andersen, Hans-Henrik Parving, and Oluf Pedersen, ‘Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes’, New England Journal of Medicine, 358.6 (2008), 580–91 <https://doi.org/10.1056/NEJMoa0706245>
Gæde, Peter, Jens Oellgaard, Bendix Carstensen, Peter Rossing, Henrik Lund-Andersen, Hans-Henrik Parving, and others, ‘Years of Life Gained by Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus and Microalbuminuria: 21 Years Follow-up on the Steno-2 Randomised Trial’, Diabetologia, 59.11 (2016), 2298–2307 <https://doi.org/10.1007/s00125-016-4065-6>
Game, Frances, ‘Classification of Diabetic Foot Ulcers’, Diabetes/Metabolism Research and Reviews, 32 (2016), 186–94 <https://doi.org/10.1002/dmrr.2746>
Giorgino, Francesco, Philip D. Home, and Jaakko Tuomilehto, ‘Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?’, Diabetes Care, 39.Supplement 2 (2016), S187–95 <https://doi.org/10.2337/dcS15-3023>
Giovanni Corona, ‘Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors’, PLoS ONE, 11.10 (2016) <https://doi.org/doi: 10.1371/journal.pone.0157915>
Hayward, Rodney A., Peter D. Reaven, Wyndy L. Wiitala, Gideon D. Bahn, Domenic J. Reda, Ling Ge, and others, ‘Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 372.23 (2015), 2197–2206 <https://doi.org/10.1056/NEJMoa1414266>
———, ‘Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 372.23 (2015), 2197–2206 <https://doi.org/10.1056/NEJMoa1414266>
Holman, Rury R., M. Angelyn Bethel, Robert J. Mentz, Vivian P. Thompson, Yuliya Lokhnygina, John B. Buse, and others, ‘Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 377.13 (2017), 1228–39 <https://doi.org/10.1056/NEJMoa1612917>
Holman, Rury R., Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews, and H. Andrew W. Neil, ‘10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes’, New England Journal of Medicine, 359.15 (2008), 1577–89 <https://doi.org/10.1056/NEJMoa0806470>
Holt, R. I. G., ‘Understanding of the Causes and Management of Diabetic Foot Disease’, Diabetic Medicine, 34.3 (2017), 303–4 <https://doi.org/10.1111/dme.13319>
Holt, Richard I. G., Textbook of Diabetes, 4th ed (Chichester: Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
Holt, Richard I. G., Clive Cockram, Allan Flyvbjerg, and Barry J. Goldstein, Textbook of Diabetes, 5th ed (Somerset: John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
Holt, Richard I. G., Clive S. Cockram, Allan Flyvbjerg, and Barry J. Goldstein, eds., Textbook of Diabetes, Fifth edition (Chichester, West Sussex, UK: Wiley Blackwell, 2017) <http://ezproxy.lib.le.ac.uk/login?url=http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=4769056>
Hotaling, James M., Aruna V. Sarma, Darshan P. Patel, Barbara H. Braffett, Patricia A. Cleary, Eva Feldman, and others, ‘Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes’, Diabetes Care, 39.9 (2016), 1587–93 <https://doi.org/10.2337/dc16-0059>
———, ‘Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes’, Diabetes Care, 39.9 (2016), 1587–93 <https://doi.org/10.2337/dc16-0059>
‘Hypertension: Clinical Management of Primary Hypertension in Adults | NICE Guideline 127. August 2011’ <http://www.nice.org.uk/guidance/cg127>
Ian Blumer, MD, FRCPC1, 2, Maureen Clement, MD, CCFP3, , ‘Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges’, Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges <http://www.sciencedirect.com.ezproxy4.lib.le.ac.uk/science/article/pii/S0149291816307792>
‘Integration of Recent Evidence into Management of Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858717300335>
‘Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes’, New England Journal of Medicine, 358.24 (2008), 2560–72 <https://doi.org/10.1056/NEJMoa0802987>
‘Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes’, New England Journal of Medicine, 353.25 (2005), 2643–53 <https://doi.org/10.1056/NEJMoa052187>
‘Intensive Systolic Blood Pressure Control and Incident Chronic Kidney Disease in People with and without Diabetes Mellitus: Secondary Analyses of Two Randomised Controlled Trials- ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300998>
International Textbook of Diabetes Mellitus, 4th edn (John Wiley & Sons, Incorporated, 2015) <http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=1895437>
Jhamb, Shaurya, Venkat N. Vangaveti, and Usman H. Malabu, ‘Genetic and Molecular Basis of Diabetic Foot Ulcers: Clinical Review’, Journal of Tissue Viability, 25.4 (2016), 229–36 <https://doi.org/10.1016/j.jtv.2016.06.005>
Jin, Dong-mei, Yun Xu, Deng-feng Geng, and Tie-bin Yan, ‘Effect of Transcutaneous Electrical Nerve Stimulation on Symptomatic Diabetic Peripheral Neuropathy: A Meta-Analysis of Randomized Controlled Trials’, Diabetes Research and Clinical Practice, 89.1 (2010), 10–15 <https://doi.org/10.1016/j.diabres.2010.03.021>
Johal, S., F. Jackson-Spence, H. Gillott, S. Tahir, J. Mytton, F. Evison, and others, ‘Pre-Existing Diabetes Is a Risk Factor for Increased Rates of Cellular Rejection after Kidney Transplantation: An Observational Cohort Study’, Diabetic Medicine, 2017 <https://doi.org/10.1111/dme.13383>
Kaul, Sanjay, ‘Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials’, Diabetes Care, 40.7 (2017), 821–31 <https://doi.org/10.2337/dc17-0291>
Khunti, K., M. L. Wolden, B. L. Thorsted, M. Andersen, and M. J. Davies, ‘Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More than 80,000 People’, Diabetes Care, 36.11 (2013), 3411–17 <https://doi.org/10.2337/dc13-0331>
Khunti, Kamlesh, Melanie Davies, Azeem Majeed, Brian Larsen Thorsted, Michael Lyng Wolden, and Sanjoy K. Paul, ‘Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study’, Diabetes Care, 38.2 (2015), 316–22 <https://doi.org/10.2337/dc14-0920>
———, ‘Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study’, Diabetes Care, 38.2 (2015), 316–22 <https://doi.org/10.2337/dc14-0920>
Koye, D. N., J. E. Shaw, C. M. Reid, R. C. Atkins, A. T. Reutens, and D. J. Magliano, ‘Incidence of Chronic Kidney Disease among People with Diabetes: A Systematic Review of Observational Studies’, Diabetic Medicine, 2017 <https://doi.org/10.1111/dme.13324>
Kunutsor, S. K., S. Seidu, and K. Khunti, ‘Aspirin for Primary Prevention of Cardiovascular and All-Cause Mortality Events in Diabetes: Updated Meta-Analysis of Randomized Controlled Trials’, Diabetic Medicine, 34.3 (2017), 316–27 <https://doi.org/10.1111/dme.13133>
Liew, G., P. Mitchell, and T. Y Wong, ‘Systemic Management of Diabetic Retinopathy’, BMJ, 338.feb12 1 (2009), b441–b441 <https://doi.org/10.1136/bmj.b441>
Lindholm, Lars H, Hans Ibsen, Björn Dahlöf, Richard B Devereux, Gareth Beevers, Ulf de Faire, and others, ‘Cardiovascular Morbidity and Mortality in Patients with Diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): A Randomised Trial against Atenolol’, The Lancet, 359.9311 (2002), 1004–10 <https://doi.org/10.1016/S0140-6736(02)08090-X>
‘Lipid-Lowering Efficacy of the PCSK9 Inhibitor Evolocumab (AMG 145) in Patients with Type 2 Diabetes: A Meta-Analysis of Individual Patient Data - ClinicalKey’ <https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858716000036>
‘Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes’, New England Journal of Medicine, 364.9 (2011), 818–28 <https://doi.org/10.1056/NEJMoa1006524>
‘Macrovascular Disease and Risk Factors in Youth with Type 1 Diabetes: Time to Be More Attentive to Treatment?- ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354>
‘———’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354>
‘———’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354>
Malavige, Lasantha S., Pabasi Wijesekara, Priyanga Ranasinghe, and Jonathan C. Levy, ‘The Association between Physical Activity and Sexual Dysfunction in Patients with Diabetes Mellitus of European and South Asian Origin: The Oxford Sexual Dysfunction Study’, European Journal of Medical Research, 20.1 (2015) <https://doi.org/10.1186/s40001-015-0186-5>
Marso, Steven P., Gilbert H. Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F.E. Mann, Michael A. Nauck, and others, ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 375.4 (2016), 311–22 <https://doi.org/10.1056/NEJMoa1603827>
Matheus, Alessandra Saldanha de Mattos, Lucianne Righeti Monteiro Tannus, Roberta Arnoldi Cobas, Catia C. Sousa Palma, Carlos Antonio Negrato, and Marilia de Brito Gomes, ‘Impact of Diabetes on Cardiovascular Disease: An Update’, International Journal of Hypertension, 2013 (2013), 1–15 <https://doi.org/10.1155/2013/653789>
Mayer-Davis, Elizabeth J., Jean M. Lawrence, Dana Dabelea, Jasmin Divers, Scott Isom, Lawrence Dolan, and others, ‘Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012’, New England Journal of Medicine, 376.15 (2017), 1419–29 <https://doi.org/10.1056/NEJMoa1610187>
Melanie Davies, ‘The Treatment of Type 2 Diabetes in the Presence of Renal Impairment: What We Should Know about Newer Therapies’, Clinical Pharmacology : Advances and Applications, 8 (2016) <https://doi.org/doi: 10.2147/CPAA.S82008>
Micha, Renata, Jose L. Peñalvo, Frederick Cudhea, Fumiaki Imamura, Colin D. Rehm, and Dariush Mozaffarian, ‘Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States’, JAMA, 317.9 (2017) <https://doi.org/10.1001/jama.2017.0947>
‘Microvascular Complications and Foot Care’, Diabetes Care, 40.Supplement 1 (2017), S88–98 <https://doi.org/10.2337/dc17-S013>
Miller, M. E, D. E Bonds, H. C Gerstein, E. R Seaquist, R. M Bergenstal, J. Calles-Escandon, and others, ‘The Effects of Baseline Characteristics, Glycaemia Treatment Approach, and Glycated Haemoglobin Concentration on the Risk of Severe Hypoglycaemia: Post Hoc Epidemiological Analysis of the ACCORD Study’, BMJ, 340.jan08 1 (2010), b5444–b5444 <https://doi.org/10.1136/bmj.b5444>
‘Minimizing Hypoglycemia in Diabetes: Table 1’, Diabetes Care, 38.8 (2015), 1583–91 <https://doi.org/10.2337/dc15-0279>
Moreton, R. B. R., I. M. Stratton, S. J. Chave, H. Lipinski, and P. H. Scanlon, ‘Factors Determining Uptake of Diabetic Retinopathy Screening in Oxfordshire’, Diabetic Medicine, 34.7 (2017), 993–99 <https://doi.org/10.1111/dme.13350>
‘Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes’, New England Journal of Medicine, 377.3 (2017), 300–301 <https://doi.org/10.1056/NEJMc1706292>
Navaneethan, Sankar D., Jesse D. Schold, Stacey E. Jolly, Susana Arrigain, Wolfgang C. Winkelmayer, and Joseph V. Nally, ‘Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD’, American Journal of Kidney Diseases, 2017 <https://doi.org/10.1053/j.ajkd.2016.11.018>
Nicolucci, A., and E. Standl, ‘Antiplatelet Therapy for Every Diabetic Person?’, Diabetes Care, 34.Supplement_2 (2011), S150–54 <https://doi.org/10.2337/dc11-s210>
‘Older Antidiabetic Drugs | The British Journal of Cardiology’ <https://bjcardio.co.uk/2018/03/older-antidiabetic-drugs/>
Omland, Torbjørn, Anna Randby, Harald Hrubos-Strøm, Helge Røsjø, and Gunnar Einvik, ‘Relation of Erectile Dysfunction to Subclinical Myocardial Injury’, The American Journal of Cardiology, 118.12 (2016), 1821–25 <https://doi.org/10.1016/j.amjcard.2016.08.070>
Orchard, Trevor J., David M. Nathan, Bernard Zinman, Patricia Cleary, David Brillon, Jye-Yu C. Backlund, and others, ‘Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-Term Mortality’, JAMA, 313.1 (2015) <https://doi.org/10.1001/jama.2014.16107>
P Naidoo, ‘Lower Limb Complications of Diabetes Mellitus: A Comprehensive Review with Clinicopathological Insights from a Dedicated High-Risk Diabetic Foot Multidisciplinary Team’, The British Journal of Radiology, 88.1053 (2015) <https://doi.org/doi: 10.1259/bjr.20150135>
Paul, Sanjoy K, Kerenaftali Klein, Brian L Thorsted, Michael L Wolden, and Kamlesh Khunti, ‘Delay in Treatment Intensification Increases the Risks of Cardiovascular Events in Patients with Type 2 Diabetes’, Cardiovascular Diabetology, 14.1 (2015) <https://doi.org/10.1186/s12933-015-0260-x>
‘Personalised Blood Pressure Ranges in Type 2 Diabetes?- ClinicalKey’ <https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2213858718300020>
‘———’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300020>
‘Personalised Treatment Targets in Type 2 Diabetes Patients: The Dutch Approach - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1751991816300626>
Pickering, Raelene J, Carlos J Rosado, Arpeeta Sharma, Shareefa Buksh, Mitchel Tate, and Judy B de Haan, ‘Recent Novel Approaches to Limit Oxidative Stress and Inflammation in Diabetic Complications’, Clinical & Translational Immunology, 7.4 (2018) <https://doi.org/10.1002/cti2.1016>
Piepoli, Massimo F., Arno W. Hoes, Stefan Agewall, Christian Albus, Carlos Brotons, Alberico L. Catapano, and others, ‘2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice’, Atherosclerosis, 252 (2016), 207–74 <https://doi.org/10.1016/j.atherosclerosis.2016.05.037>
‘Proceedings of the 5th International DAWN Summit 2014: Acting Together to Make Person-Centred Diabetes Care a Reality - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822715001862>
Rawshani, Aidin, Araz Rawshani, Stefan Franzén, Björn Eliasson, Ann-Marie Svensson, Mervete Miftaraj, and others, ‘Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes’, New England Journal of Medicine, 376.15 (2017), 1407–18 <https://doi.org/10.1056/NEJMoa1608664>
———, ‘Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes’, New England Journal of Medicine, 376.15 (2017), 1407–18 <https://doi.org/10.1056/NEJMoa1608664>
Ray, Kausik K, Sreenivasa Rao Kondapally Seshasai, Shanelle Wijesuriya, Rupa Sivakumaran, Sarah Nethercott, David Preiss, and others, ‘Effect of Intensive Control of Glucose on Cardiovascular Outcomes and Death in Patients with Diabetes Mellitus: A Meta-Analysis of Randomised Controlled Trials’, The Lancet, 373.9677 (2009), 1765–72 <https://doi.org/10.1016/S0140-6736(09)60697-8>
Richard W. Nesto, ‘LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?’, Clinical Diabetes, 26.1 (2008) <http://go.galegroup.com/ps/i.do?id=GALE|A174972167&v=2.1&u=leicester&it=r&p=EAIM&sw=w&asid=07d8e79bb8f42665bb52cc5732948c88>
Ritholz, M. D., T. MacNeil, and K. Weinger, ‘Difficult Conversations: Adults with Diabetes and the Discussion of Microvascular Complications’, Diabetic Medicine, 2017 <https://doi.org/10.1111/dme.13419>
———, ‘Difficult Conversations: Adults with Diabetes and the Discussion of Microvascular Complications’, Diabetic Medicine, 34.10 (2017), 1447–55 <https://doi.org/10.1111/dme.13419>
Romero-Aroca, Pedro, Raul Navarro-Gil, Aida Valls-Mateu, Ramon Sagarra-Alamo, Antonio Moreno-Ribas, and Nuria Soler, ‘Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-up Study’, British Journal of Ophthalmology, 2017 <https://doi.org/10.1136/bjophthalmol-2016-310063>
———, ‘Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-up Study’, British Journal of Ophthalmology, 2017 <https://doi.org/10.1136/bjophthalmol-2016-310063>
———, ‘Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-up Study’, British Journal of Ophthalmology, 2017 <https://doi.org/10.1136/bjophthalmol-2016-310063>
Rosenberg, Jamie B., and Irena Tsui, ‘Screening for Diabetic Retinopathy’, New England Journal of Medicine, 376.16 (2017), 1587–88 <https://doi.org/10.1056/NEJMe1701820>
Saha, Sandeep A., and Rohit R. Arora, ‘Fibrates in the Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus – A Pooled Meta-Analysis of Randomized Placebo-Controlled Clinical Trials’, International Journal of Cardiology, 141.2 (2010), 157–66 <https://doi.org/10.1016/j.ijcard.2008.11.211>
Santi, Daniele, Antonio R M Granata, Alessandro Guidi, Elisa Pignatti, Tommaso Trenti, Laura Roli, and others, ‘Six Months of Daily Treatment with Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial’, European Journal of Endocrinology, 174.4 (2016), 513–22 <https://doi.org/10.1530/EJE-15-1100>
Schrier, R. W., R. O. Estacio, and B. Jeffers, ‘Appropriate Blood Pressure Control in NIDDM (ABCD) Trial’, Diabetologia, 39.12 (1996), 1646–54 <https://doi.org/10.1007/s001250050629>
Scott, A. R., ‘Management of Hyperosmolar Hyperglycaemic State in Adults with Diabetes’, Diabetic Medicine, 32.6 (2015), 714–24 <https://doi.org/10.1111/dme.12757>
Seidu, S., F. A. Achana, L. J. Gray, M. J. Davies, and K. Khunti, ‘Effects of Glucose-Lowering and Multifactorial Interventions on Cardiovascular and Mortality Outcomes: A Meta-Analysis of Randomized Control Trials’, Diabetic Medicine, 33.3 (2016), 280–89 <https://doi.org/10.1111/dme.12885>
Soliman, Elsayed Z., Jye-Yu C. Backlund, Ionut Bebu, Trevor J. Orchard, Bernard Zinman, and John M. Lachin, ‘Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study’, Diabetes Care, 40.6 (2017), 793–99 <https://doi.org/10.2337/dc16-2050>
Solomon, Sharon D., Emily Chew, Elia J. Duh, Lucia Sobrin, Jennifer K. Sun, Brian L. VanderBeek, and others, ‘Diabetic Retinopathy: A Position Statement by the American Diabetes Association’, Diabetes Care, 40.3 (2017), 412–18 <https://doi.org/10.2337/dc16-2641>
———, ‘Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418’, Diabetes Care, 40.6 (2017), 809.3-809 <https://doi.org/10.2337/dc17-er06e>
———, ‘Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418’, Diabetes Care, 2017 <https://doi.org/10.2337/dc17-er06e>
———, ‘Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418’, Diabetes Care, 2017 <https://doi.org/10.2337/dc17-er06e>
Sultan, A., F. Perriard, V. Macioce, D. Mariano-Goulart, C. Boegner, J.-P. Daures, and others, ‘Evolution of Silent Myocardial Ischaemia Prevalence and Cardiovascular Disease Risk Factor Management in Type 2 Diabetes over a 10-Year Period: An Observational Study’, Diabetic Medicine, 2017 <https://doi.org/10.1111/dme.13364>
———, ‘Evolution of Silent Myocardial Ischaemia Prevalence and Cardiovascular Disease Risk Factor Management in Type 2 Diabetes over a 10-Year Period: An Observational Study’, Diabetic Medicine, 2017 <https://doi.org/10.1111/dme.13364>
‘The Changing Face of Diabetes Complications - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858716300109>
‘The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus’, New England Journal of Medicine, 329.14 (1993), 977–86 <https://doi.org/10.1056/NEJM199309303291401>
‘The Evolution of Diabetic Ketoacidosis: An Update of Its Etiology, Pathogenesis and Management - ClinicalKey’ <https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0026049515003728>
‘The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management - NHS Health Check’ <http://www.healthcheck.nhs.uk/news/the_handbook_for_vascular_risk_assessment_risk_reduction_and_risk_management/>
Turnbull, F. M., C. Abraira, R. J. Anderson, R. P. Byington, J. P. Chalmers, W. C. Duckworth, and others, ‘Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes’, Diabetologia, 52.11 (2009), 2288–98 <https://doi.org/10.1007/s00125-009-1470-0>
———, ‘Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes’, Diabetologia, 52.11 (2009), 2288–98 <https://doi.org/10.1007/s00125-009-1470-0>
‘Type 1 Diabetes in Adults: Diagnosis and Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng17>
‘Type 2 Diabetes in Adults: Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng28>
UK Prospective Diabetes Study Group, ‘Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38’, BMJ : British Medical Journal, 317.7160 (1998) <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC28659/>
Umpierrez, Guillermo, and Mary Korytkowski, ‘Diabetic Emergencies — Ketoacidosis, Hyperglycaemic Hyperosmolar State and Hypoglycaemia’, Nature Reviews Endocrinology, 12.4 (2016), 222–32 <https://doi.org/10.1038/nrendo.2016.15>
———, ‘Diabetic Emergencies — Ketoacidosis, Hyperglycaemic Hyperosmolar State and Hypoglycaemia’, Nature Reviews Endocrinology, 12.4 (2016), 222–32 <https://doi.org/10.1038/nrendo.2016.15>
Valencia, Willy Marcos, and Hermes Florez, ‘How to Prevent the Microvascular Complications of Type 2 Diabetes beyond Glucose Control’, BMJ, 2017 <https://doi.org/10.1136/bmj.i6505>
Wannamethee, S. Goya, A. Gerald Shaper, Peter H. Whincup, Lucy Lennon, and Naveed Sattar, ‘Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men: Influence of Age at Onset, Diabetes Duration and Established and Novel Rosk Factors’, Archives of Internal Medicine, 171.5 (2011) <https://doi.org/10.1001/archinternmed.2011.2>
Webb, D. R., F. Zaccardi, M. J. Davies, S. J. Griffin, N. J. Wareham, R. K. Simmons, and others, ‘Cardiovascular Risk Factors and Incident Albuminuria in Screen-Detected Type 2 Diabetes’, Diabetes/Metabolism Research and Reviews, 2016 <https://doi.org/10.1002/dmrr.2877>
Weber, Michael A., George L. Bakris, Kenneth Jamerson, Matthew Weir, Sverre E. Kjeldsen, Richard B. Devereux, and others, ‘Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes’, Journal of the American College of Cardiology, 56.1 (2010), 77–85 <https://doi.org/10.1016/j.jacc.2010.02.046>
Whelton, Paul K., ‘Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia’, Archives of Internal Medicine, 165.12 (2005) <https://doi.org/10.1001/archinte.165.12.1401>
White, Jon, Daniel I. Swerdlow, David Preiss, Zammy Fairhurst-Hunter, Brendan J. Keating, Folkert W. Asselbergs, and others, ‘Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes’, JAMA Cardiology, 1.6 (2016) <https://doi.org/10.1001/jamacardio.2016.1884>
Wong, Muh Geot, Vlado Perkovic, John Chalmers, Mark Woodward, Qiang Li, Mark E. Cooper, and others, ‘Long-Term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON’, Diabetes Care, 39.5 (2016), 694–700 <https://doi.org/10.2337/dc15-2322>
———, ‘Long-Term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON’, Diabetes Care, 39.5 (2016), 694–700 <https://doi.org/10.2337/dc15-2322>
Yavuz, Metin, Ali Ersen, Jessica Hartos, Brandy Schwarz, Alan G. Garrett, Lawrence A. Lavery, and others, ‘Plantar Shear Stress in Individuals With a History of Diabetic Foot Ulcer: An Emerging Predictive Marker for Foot Ulceration’, Diabetes Care, 40.2 (2017), e14–15 <https://doi.org/10.2337/dc16-2204>
Yudkin, John S, Bernd Richter, and Edwin AM Gale, ‘Intensified Glucose Control in Type 2 Diabetes—Whose Agenda?’, The Lancet, 377.9773 (2011), 1220–22 <https://doi.org/10.1016/S0140-6736(10)61112-9>
Zaccardi, Francesco, David R. Webb, Melanie J. Davies, Nafeesa N. Dhalwani, Laura J. Gray, Sudesna Chatterjee, and others, ‘Predicting Hospital Stay, Mortality and Readmission in People Admitted for Hypoglycaemia: Prognostic Models Derivation and Validation’, Diabetologia, 2017 <https://doi.org/10.1007/s00125-017-4235-1>
Zaccardi, Francesco, David R. Webb, Melanie J. Davies, Nafeesa N. Dhalwani, Gemma Housley, Dominic Shaw, and others, ‘Risk Factors and Outcome Differences in Hypoglycaemia-Related Hospital Admissions: A Case-Control Study in England’, Diabetes, Obesity and Metabolism, 2017 <https://doi.org/10.1111/dom.12941>
Zhang, Chun-Yu, Ai-Jun Sun, Shu-Ning Zhang, Chao-neng Wu, Ming-Qiang Fu, Guang Xia, and others, ‘Effects of Intensive Glucose Control on Incidence of Cardiovascular Events in Patients with Type 2 Diabetes: A Meta-Analysis’, Annals of Medicine, 42.4 (2010), 305–15 <https://doi.org/10.3109/07853891003796752>
Zinman, Bernard, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, and others, ‘Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes’, New England Journal of Medicine, 373.22 (2015), 2117–28 <https://doi.org/10.1056/NEJMoa1504720>
Zoungas, Sophia, Hisatomi Arima, Hertzel C Gerstein, Rury R Holman, Mark Woodward, Peter Reaven, and others, ‘Effects of Intensive Glucose Control on Microvascular Outcomes in Patients with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomised Controlled Trials’, The Lancet Diabetes & Endocrinology, 5.6 (2017), 431–37 <https://doi.org/10.1016/S2213-8587(17)30104-3>
